Page last updated: 2024-09-05

symmetric dimethylarginine and ezetimibe

symmetric dimethylarginine has been researched along with ezetimibe in 1 studies

Compound Research Comparison

Studies
(symmetric dimethylarginine)
Trials
(symmetric dimethylarginine)
Recent Studies (post-2010)
(symmetric dimethylarginine)
Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010) (ezetimibe)
428273142,4845631,465

Protein Interaction Comparison

ProteinTaxonomysymmetric dimethylarginine (IC50)ezetimibe (IC50)
NPC1-like intracellular cholesterol transporter 1Homo sapiens (human)0.37

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brykner, R; Cwynar-Zając, Ł; Dzięgiel, P; Ewa Chlebda-Sieragowska, E; Fereniec-Gołębiewska, L; Gomułkiewicz, A; Kwiatkowska, J; Merwid-Ląd, A; Pieśniewska, M; Sozański, T; Szeląg, A; Szuba, A; Trocha, M1

Other Studies

1 other study(ies) available for symmetric dimethylarginine and ezetimibe

ArticleYear
Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Pharmacological reports : PR, 2013, Volume: 65, Issue:1

    Topics: Amidohydrolases; Animals; Anticholesteremic Agents; Arginine; Azetidines; Ezetimibe; Liver; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Reperfusion Injury; RNA, Messenger; Time Factors

2013